Insider Trading & Ownership of Erik Harris

Location: Redwood City, CA
Summary: The estimated net worth of Erik Harris is at least $4,239,376 dollars as of 21 Nov 2025. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $3.7M. Erik Harris is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $347.7K. Erik Harris is the Director of Rezolute, Inc. and owns shares of Rezolute, Inc. (RZLT) stock worth about $193K.
Signature: /s/ Erik Harris
All Insider Reports: All Insider Reports

Notify me when Erik Harris files a new Insider Trading report.

Ownership of Erik Harris

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RARE	Ultragenyx Pharmaceutical Inc.	EVP & Chief Commercial Officer	$3,698,696	-$635,836	-15%	01 Mar 2025
DNLI	Denali Therapeutics Inc.	Director	$347,690			31 May 2024
RZLT	Rezolute, Inc.	Director	$192,990			19 Nov 2025
INZY	Inozyme Pharma, Inc.	Director				03 Oct 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.